Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (37)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Carlisle, D. L.
Right arrow Articles by Patierno, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carlisle, D. L.
Right arrow Articles by Patierno, S. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 55, 60-68 (2000)
Copyright © 2000 by the Society of Toxicology


Carcinogenicity

Apoptosis and P53 Induction in Human Lung Fibroblasts Exposed to Chromium (VI): Effect of Ascorbate and Tocopherol

D. L. Carlisle*,{ddagger}, D. E. Pritchard*, J. Singh*, B. M. Owens*,{ddagger}, L. J. Blankenship*, J. M. Orenstein{dagger} and S. R. Patierno*,{ddagger},1

* Departments of Pharmacology and {dagger} Pathology, and Programs in {ddagger} Molecular and Cellular Oncology and § Genetics, The George Washington University Medical Center, Washington, DC 20037

Some forms of hexavalent chromium [Cr(VI)] are known to cause damage to respiratory tract tissue, and are thought to be human lung carcinogens. Because Cr(VI) is mutagenic and carcinogenic at doses that evoke cell toxicity, the objective of these experiments was to examine the effect of Cr(VI) on the growth, survival, and mode of cell death in normal human lung fibroblasts (HLF cells). DNA adduct formation was monitored as a marker for bioavailability of genotoxic chromium. We also examined the modulation of these endpoints by vitamins C and E. Long-term Cr(VI) exposures were employed, which decreased clonogenic cell survival by 25% to 95% in a dose-dependent manner. The predominant cellular response to Cr(VI) was growth arrest. We found that Cr(VI) caused up to 20% of HLF cells to undergo apoptosis, and documented apoptotic morphology and the phagocytosis of apoptotic bodies by neighboring cells. P53 levels increased 4- to 6-fold in chromium-treated cells. In contrast with previous studies using CHO cells, the present study using HLFs found that pretreatment with either vitamin C or E did not exhibit a significant effect on Cr-induced apoptosis or clonogenic survival. In addition, pretreatment with vitamin C did not affect the p53 induction observed after chromium treatment. Neither vitamin had any effect on Cr-DNA adduct formation. These data indicate that although pretreatment with vitamin C or E alters the spectrum of cellular and/or genetic lesions induced by chromium(VI), neither vitamin altered the initiation or progression of apoptosis in diploid human lung cells.

Key Words: genotoxicity; carcinogenesis; ascorbate; tocopherol; LL-24 cells; clonogenic survival; electron microscopy.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
M. Reynolds and A. Zhitkovich
Cellular vitamin C increases chromate toxicity via a death program requiring mismatch repair but not p53
Carcinogenesis, July 1, 2007; 28(7): 1613 - 1620.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
P. Russo, A. Catassi, A. Cesario, A. Imperatori, N. Rotolo, M. Fini, P. Granone, and L. Dominioni
Molecular Mechanisms of Hexavalent Chromium-Induced Apoptosis in Human Bronchoalveolar Cells
Am. J. Respir. Cell Mol. Biol., December 1, 2005; 33(6): 589 - 600.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
I. Martin-Burriel, N. O. Roome, O. Dorchies, and A. Prenez
Histopathological and Molecular Changes During Apoptosis Produced by 7H-Dibenzo[c,g]-Carbazole in Mouse Liver
Toxicol Pathol, February 1, 2004; 32(2): 202 - 211.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
L. Ha, S. Ceryak, and S. R. Patierno
Chromium (VI) Activates Ataxia Telangiectasia Mutated (ATM) Protein. REQUIREMENT OF ATM FOR BOTH APOPTOSIS AND RECOVERY FROM TERMINAL GROWTH ARREST
J. Biol. Chem., May 9, 2003; 278(20): 17885 - 17894.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
F. D'Agostini, A. Izzotti, C. Bennicelli, A. Camoirano, E. Tampa, and S. De Flora
Induction of apoptosis in the lung but not in the liver of rats receiving intra-tracheal instillations of chromium(VI)
Carcinogenesis, April 1, 2002; 23(4): 587 - 593.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
D. E. Pritchard, S. Ceryak, L. Ha, J. L. Fornsaglio, S. K. Hartman, T. J. O'Brien, and S. R. Patierno
Mechanism of Apoptosis and Determination of Cellular Fate in Chromium(VI)-exposed Populations of Telomerase-immortalized Human Fibroblasts
Cell Growth Differ., October 1, 2001; 12(10): 487 - 496.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. E. Pritchard, J. Singh, D. L. Carlisle, and S. R. Patierno
Cyclosporin A inhibits chromium(VI)-induced apoptosis and mitochondrial cytochrome c release and restores clonogenic survival in CHO cells
Carcinogenesis, November 1, 2000; 21(11): 2027 - 2033.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. P. Waalkes, D. A. Fox, J. C. States, S. R. Patierno, and M. J. McCabe Jr.
Metals and Disorders of Cell Accumulation: Modulation of Apoptosis and Cell Proliferation
Toxicol. Sci., August 1, 2000; 56(2): 255 - 261.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.